Question · asked by 1 review
Cannabis‐based medicines vs placebo: Serious adverse events
- Population
- adults with chronic neuropathic pain
- Intervention
- Cannabis‐based medicines
- Comparison
- placebo
- Outcome
- Serious adverse events
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Cannabis‐based medicines vs placebo Serious adverse events · adults with chronic neuropathic pain Cannabis‐based medicines for chronic neuropathic pain in adults (2018) · Cochrane Headline outcomes only | no estimate extracted | 13 studies · 1876 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Cannabis‐based medicines for chronic neuropathic pain in adults 2018 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.